The Recall That Passed Every Test
West Coast Cure’s recall shows why testing and insurance answer different questions. A passing test does not eliminate the financial risk of a later recall.
NEW YORK — California’s Department of Cannabis Control issued a mandatory recall for a West Coast Cure CUREpen vape-cartridge product on July 2, 2024, citing chlorfenapyr contamination. For an operator, a recall creates immediate questions about product recovery, lost sales and who pays.
The uncomfortable lesson is that in cannabis, recalls reach careful companies, too. And they are no longer rare. California averaged about three cannabis recalls a year in 2022 and 2023; in 2024, it issued sixty-three recall notices covering 259 products and nearly 25,000 units, according to state enforcement data reported by MJBizDaily. Colorado logged seventeen recalls in 2025, including one covering 710 Labs flower and pre-rolls sold at 172 retailers and another, on New Year’s Eve, involving CC Brands products sold at 295 dispensaries, according to Colorado Public Radio and Westword. In 2023, Missouri recalled about 62,800 products associated with untracked material and missing required testing.
Who pays
Most operators assume their insurance will respond. Usually it won’t. Product-liability coverage answers third-party claims—a customer who says she was hurt. It does not pay a company’s own cost of pulling product from shelves, destroying it under witness, retesting what remains, answering regulators, and going weeks without sales. In the surplus-lines market that serves cannabis, recall coverage at meaningful limits is often excluded or simply unavailable.
The bill can be ruinous. Reported losses from Missouri’s 2023 recall included approximately $2 million of unusable oil at one manufacturer and up to $200,000 of lost revenue at a dispensary chain. These are reported company estimates, not a general recall-cost model.
Paying for it before it happens
Some operators have stopped leaving recall risk to chance. They finance it in advance, through an insurance company they own. A captive insurance company can write recall coverage shaped to the way cannabis recalls unfold: witnessed destruction, retesting, legal and regulatory response, lost income while product is off the shelf, and, in some structures, the cost of restoring a brand’s reputation.
The structure fits the risk. For any one company, a recall is unlikely in a given year and devastating when it comes. Premiums build reserves during the quiet years. When the notice arrives, the money is there. If it never arrives, the reserves remain the company’s capital, earning investment income, instead of a carrier’s profit.
The return on caution
There is a second, quieter payoff. When a company insures its own recalls, every recall avoided is money it keeps. Quality control stops being overhead and becomes an investment with a measurable return. The operator has every reason to audit its hardware and distillate suppliers, test beyond the state minimum when an input changes, use more than one laboratory, and keep batch records precise enough to narrow a recall to a single lot.
Medicine learned this long ago. When Harvard’s hospitals began insuring their own malpractice risk, in 1976, they soon found that the cheapest claim was the one prevented, and they cut some doctors’ premiums by a third once new safety standards took hold. The cannabis equivalent is the recall that never happens.
The math worth doing
Recall coverage through a captive suits operators with the scale to fund reserves and a record steady enough to price. Smaller companies can share the cost through a group captive or a protected cell. An independent actuary must price the policy on real exposure, which also makes it defensible to regulators and tax authorities.
After two years of rising recall notices, no operator can call the risk remote. The real question is financial: whether to fund the cost in advance, on the company’s own terms, or to meet it for the first time in a regulator’s letter.

By Patrick Johnston, Co-Founder, 3F Captive Services
Patrick Johnston is co-founder of 3F Captive Services, which helps mid-sized businesses form and manage captive insurance companies. He has spent more than twenty years running and investing in businesses: he operated a dairy, has owned S&P Ranch, LLC, a California specialty-crop grower, since 2008, and has been chief executive of AgCentra Capital Management since 2016. He co-founded 3F in 2022 and works with owners in agriculture, cannabis, transportation and logistics, construction, health care, hospitality, and professional services. He holds a B.A. in economics from the University of Washington and an M.B.A. from Northwestern University’s Kellogg School of Management.
This is sponsored content. It was written by Patrick Johnston of 3F Captive Services and published by HCN in partnership with 3F Captive Services. It is for general information only and is not insurance, tax, or legal advice. Readers should consult their own qualified advisers.






































